pharmaphorumconnect.com

pharmaphorum.com

Scotland accepts HIV drug Rezolsta, rejects cancer drug Xtandi - Pharmaphorum

http://pharmaphorum.com/news/scotland-accepts-hiv-drug-rezolsta-rejects-cancer-drug-xtandi

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. Scotland accepts HIV drug Rezolsta, rejects cancer drug Xtandi. HIV treatment Rezolsta is one of three new drugs accepted for use by the Scottish Medicines Consortium (SMC). Janssen’s Rezolsta combines protease inhibitor darunavir (Janssen’s Pr...The Spiri...

pharmaphorum.com

Contribute - Pharmaphorum

http://pharmaphorum.com/contribute

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. If you enjoy reading the content on. And want to get more actively involved there are a number of ways you can contribute. Publishing on. Is a great way to put yourself in front of our sizeable global pharma audience. Or complete the contact form below.

pharmaphorum.com

Advertise - Pharmaphorum

http://pharmaphorum.com/advertise

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. 8220;We are so often defined by the company we keep”. Pharmaphorum offers a number of ways to position you in front of our global audience of pharma decision makers and alongside our valued industry brand. Sponsorship banners / monthly partnership. In addi...

pharmaphorum.com

Finding commercial success via patient outcomes - Pharmaphorum

http://pharmaphorum.com/articles/finding-commercial-success-via-patient-outcomes

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. Finding commercial success via patient outcomes. Recent research suggests that companies which focus on turning science into value through demonstrating benefits to patients will ride the wave of increasing investor confidence in the US pharma industry.

pharmaphorum.com

Our Team - Pharmaphorum

http://pharmaphorum.com/our-team

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. Paul Tunnah, CEO. View Paul’s profile. View Paul’s profile. Linda Banks – Commissioning Editor – Thought Leaders. View Linda’s profile. View Linda’s profile. Louise Bellamy, Senior Account Manager. View Louise’s profile. View Christian’s profile. New busin...

pharmaphorum.com

Fragile X treatment gets catalyst funding - Pharmaphorum

http://pharmaphorum.com/news/fragile-x-treatment-gets-catalyst-funding

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. Fragile X treatment gets catalyst funding. Twelve exciting new treatments, diagnostics and medical technologies are to receive a total of 18 million ($27.8 million) from a UK government research fund. The funding announcement doesn’t disclose the mec...

pharmaphorum.com

Articles Archives - Pharmaphorum

http://pharmaphorum.com/articles

Views & analysis. Charity raises funds for legal fight over HIV drug. Anthill awarded full Veeva certification. The UK’s PPRS and statutory schemes. Sandoz’s Enbrel biosimilar approved in US. Boehringer and Qualcomm collaborate on digital COPD inhaler. The UK’s PPRS and statutory schemes. Do the PPRS and the statutory scheme run effectively in parallel? The UK’s PPRS and statutory schemes. New business models turn science into market value. Delivering better patient benefit and economic returns. A round-...

pharmaphorum.com

Facing multiple sclerosis: a united approach - Pharmaphorum

http://pharmaphorum.com/articles/facing-multiple-sclerosis-together

Views & analysis. The biggest pharma stories of 2016 so far. Clinton attacks Mylan over drug pricing. Smartphone app lets doctors deliver health info directly to patients. Mylan and Biocon file Herceptin biosimilar in Europe. F-star and Denali sign potential $1bn antibody deal. Facing multiple sclerosis: a united approach. What do people with MS need in terms of support beyond drugs? There are five main things that people with MS need beyond drugs:. 1 Information, education and advice. Produce excellent ...

pharmaphorum.com

Lessons in building value for pharma - Pharmaphorum

http://pharmaphorum.com/articles/lessons-in-building-value-for-pharma

Views & analysis. Digital diabetes adherence network plans to be largest in US by 2017. Digital health round-up: Google Genomics, cancer bots & more. Merck, Pfizer and Gilead all interested in Medivation buy-out. NICE says no to liver cancer drug Nexavar. Single vaccine against Zika and Dengue to be developed. Lessons in building value for pharma. Here, pharmaphorum speaks with Ian Evetts, an industry veteran with experience on both the biotech and pharma sides of the fence, to hear his thoughts on how p...